Skip header and navigation

Narrow By

   MORE

34 records – page 1 of 2.

Cancer related brain fog

https://libcat.nshealth.ca/en/permalink/chpams37382
Nova Scotia Health Authority. Central Zone. Radiation Team, Nova Scotia Health. Cancer Care Program. Halifax, NS: Nova Scotia Health Cancer Care Program , 2022.
Pamphlet Number
4029
Available Online
View Pamphlet
Cancer patients and survivors can be frustrated by the mental cloudiness they notice before, during, and after cancer treatment. This common cancer side effect is called Brain Fog or Chemo Brain. The term Chemo Brain can be misleading as chemotherapy is not the only cause of concentration and memory problems. This pamphlet explains what brain fog is, what causes it, the risk factors for brain fog, and what you can do to manage it. A list of resources for further information is included.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Central Zone. Radiation Team
Nova Scotia Health. Cancer Care Program
Alternate Title
Cancer-related brain fog
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Cancer Care Program
Date of Publication
2022
Format
Pamphlet
Language
English
Physical Description
1 electronic document (5 p.) : digital, PDF file
Subjects (MeSH)
Drug-Related Side Effects and Adverse Reactions
Neoplasms - complications
Neoplasms - psychology
Patients - psychology
Subjects (LCSH)
Cancer--Chemotherapy--Complications
Cancer--Patients--Psychology
Specialty
Cancer Care
Abstract
Cancer patients and survivors can be frustrated by the mental cloudiness they notice before, during, and after cancer treatment. This common cancer side effect is called Brain Fog or Chemo Brain. The term Chemo Brain can be misleading as chemotherapy is not the only cause of concentration and memory problems. This pamphlet explains what brain fog is, what causes it, the risk factors for brain fog, and what you can do to manage it. A list of resources for further information is included.
Responsibility
Prepared by: NSH Central Zone Radiation Team
Pamphlet Number
4029
Less detail

Chemotherapy in Neonates and Infants : Pharmacological Oncology for Children Under 1 Year Old

https://libcat.nshealth.ca/en/permalink/provcat42571
Carolina Witchmichen Penteado Schmidt. --Cham: Springer , c2018.
Available Online
View e-Book
Location
Online
This book provides a comprehensive overview of pediatric oncology, discussing drug therapy and treatment in children under the age of 1 year. It is the first volume to focus on chemotherapy in newborns and infants, especially the daily clinical practice and treatment protocols. Intended as a practical manual, it addresses all the major topics related to pediatric oncology in an accessible and easy-to-use format. It examines topics in pediatric oncology therapeutics, including drug metabolism, e…
Available Online
View e-Book
Author
Penteado Schmidt, Carolina Witchmichen
Responsibility
Carolina Witchmichen Penteado Schmidt
Place of Publication
Cham
Publisher
Springer
Date of Publication
c2018
Physical Description
1 online resource (xix, 198 p.) : 8 illus. in color
ISBN
9783319705910
9783319705903 (print ed.)
9783319705927 (print ed.)
Subjects (MeSH)
Antineoplastic Agents - pharmacology
Drug-Related Side Effects and Adverse Reactions - prevention & control
Infant
Infant, Newborn
Neoplasms - drug therapy
Specialty
Medical Oncology
Pediatrics
Pharmacology
Abstract
This book provides a comprehensive overview of pediatric oncology, discussing drug therapy and treatment in children under the age of 1 year. It is the first volume to focus on chemotherapy in newborns and infants, especially the daily clinical practice and treatment protocols. Intended as a practical manual, it addresses all the major topics related to pediatric oncology in an accessible and easy-to-use format. It examines topics in pediatric oncology therapeutics, including drug metabolism, excretion, toxicity, drugs that can be used for each week or month of the patient's life, dose adjustment and treatment protocols. Chemotherapy in Neonates and Infants focuses on the safe treatment of children in the first year of life, and is aimed at pediatric oncology/hematology institutions, clinics and departments. It is particularly valuable for researchers, pediatric oncology physicians, pediatric and neonatology physicians, oncology pharmacists and the other healthcare professionals directly involved in the chemotherapy of neonates and infants.
Contents
1. Introduction -- 2. Protocols Used in Chemotherapy Treatment of Neonates and Infants -- 3. Pharmacokinetics and Pharmacodynamics of Chemotherapy Drugs in Neonates and Infants -- 4. Peculiarities of Most Commonly Used Chemotherapy Drugs in Neonates and Infants -- 5. Adjuvant Drugs Used in Chemotherapy for Neonates and Infants -- 6. Drug Interactions in Neonates and Infants -- 7. Toxicity -- 8. Tumor Lysis in Neonates and Infants -- 9. Chemotherapy in Neonates and Infants with Cancer and Other Congenital Diseases: Down Syndrome and HIV -- 10. Stem Cell Transplantation in Neonates and Infants.
Format
e-Book
Location
Online
Less detail

Drug Allergy : Clinical Aspects, Diagnosis, Mechanisms, Structure-Activity Relationships

https://libcat.nshealth.ca/en/permalink/provcat46495
Brian A. Baldo, Nghia H. Pham. (Second edition) --Cham: Springer , c2021.
Available Online
View e-Book
Access
NEW Springer 2021
Location
Online
The second edition of this book spans the broad range of modern therapeutic drugs, from small molecules to biologic recombinant proteins. It offers a comprehensive review of the classification and description of different drug-induced systemic and cutaneous hypersensitivities; an up-to-date coverage of individual culprit drugs in each group of therapeutics; the diagnosis and mechanisms of reactions; and important structure-activity relationships. New content expands to two areas of drug allergy…
Available Online
View e-Book
Author
Baldo, Brian A.
Other Authors
Pham, Nghia H.
Responsibility
Brian A. Baldo, Nghia H. Pham
Edition
Second edition
Place of Publication
Cham
Publisher
Springer
Date of Publication
c2021
Physical Description
1 online resource (xxii, 732 p.) : 330 illus., 162 illus. in color
ISBN
9783030517403
9783030517397 (Print ed.)
9783030517410 (Print ed.)
9783030517427 (Print ed.)
Subjects (MeSH)
Drug Hypersensitivity
Drug-Related Side Effects and Adverse Reactions
Structure-Activity Relationship
Specialty
Allergy and Immunology
Pharmacology
Toxicology
Abstract
The second edition of this book spans the broad range of modern therapeutic drugs, from small molecules to biologic recombinant proteins. It offers a comprehensive review of the classification and description of different drug-induced systemic and cutaneous hypersensitivities; an up-to-date coverage of individual culprit drugs in each group of therapeutics; the diagnosis and mechanisms of reactions; and important structure-activity relationships. New content expands to two areas of drug allergy that have recently experienced explosive growth: biological therapies and new targeted chemotherapies. Other new and expanded chapters address antimicrobials; drugs used in anesthesia and surgery; opioids; non-targeted anti-cancer drugs; vaccines; and newly understood reaction mechanisms. This new edition includes photographs of a wide variety of cutaneous manifestations that will be of use to other clinicians as well as allergists and dermatologists. In addition to its wide clinical emphasis, the book’s mechanistic and structure-activity detail will provide valuable background for researchers and investigators in universities, medical research institutes, drug companies, and regulatory agencies. The second edition of Drug Allergy is an essential reference for practitioners across the medical disciplines from specialist clinicians, surgeons, GPs, residents, and medical students to nurses, pharmacists, dentists, and those taking undergraduate and graduate courses in the biomedical sciences.
Contents
1. Scope of this Book: Adverse Reactions to Drugs and Drug Allergy -- 2. Classification and Descriptions of Allergic Reactions to Drugs -- 3. Mechanisms of Hypersensitivity -- 4. Diagnosis of Allergic Reactions to Drugs -- 5. ß-Lactam Antibiotics -- 6. Other Antimicrobial Drugs -- 7. Drugs and Other Agents Used in Anesthesia and Surgery -- 8. Opioid Analgesic Drugs -- 9. Non-steroidal Anti-inflammatory Drugs -- 10. Contrast Media -- 11. Corticosteroids -- 12. Proton Pump Inhibitors -- 13. Biologics: Monoclonal Antibodies for Non-cancer Therapy, Cytokines, Fusion Proteins, Enzymes, and Hormones -- 14. Targeted Drugs for Cancer Therapy: Small Molecules and Monoclonal Antibodies -- 15. Non-targeted Drugs for Cancer Therapy -- 16. Vaccines.
Access
NEW Springer 2021
Format
e-Book
Location
Online
Less detail

Drug-Induced Lung Injury

https://libcat.nshealth.ca/en/permalink/provcat42876
edited by Masayuki Hanaoka, Hiroyuki Nakamura, Kazutetsu Aoshiba. --Singapore: Springer , c2018.
Available Online
View e-Book
Location
Online
.
Available Online
View e-Book
Other Authors
Hanaoka, Masayuki
Nakamura, Hiroyuki
Aoshiba, Kazutetsu
Responsibility
edited by Masayuki Hanaoka, Hiroyuki Nakamura, Kazutetsu Aoshiba
Place of Publication
Singapore
Publisher
Springer
Date of Publication
c2018
Physical Description
1 online resource (viii, 215 p.) : 53 illus., 15 illus. in color
Series
Respiratory Disease Series: Diagnostic Tools and Disease Managements
Series Title
Respiratory disease series
ISBN
9789811044663
9789811044656 (print ed.)
9789811044670 (print ed.)
ISSN
2509-5552
Subjects (MeSH)
Drug-Related Side Effects and Adverse Reactions - diagnosis
Drug Toxicity
Lung Injury - chemically induced
Lung Injury - diagnosis
Lung - drug effects
Risk Factors
Specialty
Pharmacology
Pulmonary Medicine
Abstract
.
Contents
Part I. Definition, Pathogenesis, and Epidemiology -- 1. Definition, Pathogenesis and Epidemiology: What is DLI? -- 2. Epidemiology and Risk Factors of Drug-Induced Lung Disease: What are the prevalence and risk factors of DLI? -- 3. Clinical Characteristics of DLI: What are the clinical features of DLI? -- Part II. Diagnosis -- 4. Diagnostic Approach for DLI: How is DLI diagnosed? -- 5. Blood tests for the diagnosis and/or management of DLI: What are the clinical significances of KL-6, SP-A, SP-D and DLST in DLI? -- 6. Imaging features of drug-induced interstitial lung disease: How HRCT of DLI is interpreted? -- 7. Pathology of DLI: What is the pathological significance of DLI? -- 8. Differential Diagnosis of DLI: What are the differential diagnoses of DLI? -- Part III. Treatment -- 9. Therapeutic Strategies for DLI: How should DLI be treated? -- Part IV Drugs Causing DLI -- 10. DLI induced by non-molecular target antineoplastic drugs: What are the characteristics of DLI in non-molecular target antineoplastic drugs? -- 11. DLI induced by Molecular Target Antineoplastic Drug: What are the characteristics of DLI in molecular target antineo-plastic drugs? -- 12. DLI caused by disease-modifying antirheumatic drugs: What are the characteristics of DLI by disease-modifying antirheumatic drugs? -- 13. DLI Induced by Herbal Medicine: What are the characteristics of DLI due to herbal medicines? -- 14. DLI induced by Antiarrhythmic Drug and Antimicrobial Drug: What are the characteristics of DLI in antiarrhythmic drugs and antimicrobial drugs?.
Format
e-Book
Location
Online
Less detail

Drug-induced ocular side effects

https://libcat.nshealth.ca/en/permalink/provcat42359
Frederick "Fritz" T. Fraunfelder, Frederick "Rick" W. Fraunfelder. (8th ed.) --London, UK: Elsevier , c2021.
Available Online
View e-Book
Access
Registration required for PDF access.
Location
Online
Available Online
View e-Book
Author
Fraunfelder, Frederick
Responsibility
Frederick "Fritz" T. Fraunfelder, Frederick "Rick" W. Fraunfelder
Edition
8th ed.
Alternate Title
Drug induced ocular side effects
Ocular side effects
Place of Publication
London, UK
Publisher
Elsevier
Date of Publication
c2021
Physical Description
1 online resource
ISBN
9780323653756
Subjects (MeSH)
Drug-Related Side Effects and Adverse Reactions
Eye Diseases - chemically induced
Eye - drug effects
Toxicology - methods
Specialty
Ophthalmology
Pharmacology
Access
Registration required for PDF access.
Format
e-Book
Location
Online
Less detail

Drug-induced ocular side effects

https://libcat.nshealth.ca/en/permalink/provcat50625
Fraunfelder, Frederick T. (8th ed.) --Philadelphia, PA: Elsevier , 2021.
Available Online
View e-Book
Location
Online
Available Online
View e-Book
Author
Fraunfelder, Frederick T.
Edition
8th ed.
Place of Publication
Philadelphia, PA
Publisher
Elsevier
Date of Publication
2021
ISBN
9780323653756
Subjects (MeSH)
Toxicology - methods
Eye Diseases - chemically induced
Eye - drug effects
Drug-Related Side Effects and Adverse Reactions
Notes
Access to this online resource is restricted to IWK Health Centre employees working from inside the hospital network.
Format
e-Book
Location
Online
Less detail

Drugs During Pregnancy : Methodological Aspects

https://libcat.nshealth.ca/en/permalink/provcat40291
Bengt Källén. --Cham: Springer , c2016.
Available Online
View e-Book
Location
Online
This book addresses methodological aspects of epidemiological studies on maternal drug use in pregnancy. Discussing the existing sources of error and how they can produce incorrect conclusions, it examines various epidemiological techniques and assesses their strengths and weaknesses. These refer both to the identification of outcomes (with special emphasis on congenital malformations) and to the types of exposure (drug use). Further, the book discusses the problem of confounding and how to han…
Available Online
View e-Book
Author
Källén, Bengt
Responsibility
Bengt Källén
Place of Publication
Cham
Publisher
Springer
Date of Publication
c2016
Physical Description
1 online resource (xi, 111 p. : 26 illus. in color)
ISBN
9783319406978
9783319406961 (print ed.)
Subjects (MeSH)
Abnormalities, Drug-Induced - etiology
Confounding Factors (Epidemiology)
Drug Therapy - contraindications
Drug-Related Side Effects and Adverse Reactions
Embryonic Structures - drug effects
Epidemiologic Methods
Pharmacoepidemiology
Pregnancy - drug effects
Abstract
This book addresses methodological aspects of epidemiological studies on maternal drug use in pregnancy. Discussing the existing sources of error and how they can produce incorrect conclusions, it examines various epidemiological techniques and assesses their strengths and weaknesses. These refer both to the identification of outcomes (with special emphasis on congenital malformations) and to the types of exposure (drug use). Further, the book discusses the problem of confounding and how to handle it, and provides a simple introduction to statistics. Special situations, e.g. different types of parental exposure, are examined. Lastly, the book discusses pharmacovigilance and the information problem, concluding with a short list of aspects to consider when one wants to evaluate a published paper in the field. Though the book is primarily intended for pharmacologists, gynecologists and obstetricians, it will benefit all doctors working in perinatal care.
Contents
Introduction -- The alert clinician -- Animal experiments and adverse drug reaction reports -- Some epidemiological principles -- Pregnancy outcomes with the exception of congenital malformations -- Congenital malformations -- Identification of maternal use of drugs -- The problem of confounding -- Statistics for dummies -- Lumping or splitting? -- Timing of drug use and effects on the embryo or fetus -- Repeated studies and meta-analysis -- The identification of risks and the information problem.
Format
e-Book
Location
Online
Less detail

Drugs for pregnant and lactating women

https://libcat.nshealth.ca/en/permalink/provcat42512
Carl P. Weiner, Clifford Mason. (3rd ed.) --Philadelphia, PA: Elsevier , c2019.
Available Online
View e-Book
Access
Registration required for PDF access.
Location
Online
Comprehensive and easy to use, Drugs for Pregnant and Lactating Women, 3rd Edition, remains your #1 resource for reliable information on virtually all of today’s drugs and herbal supplements and how they interact with pregnancy and lactation. This logically organized reference has been frequently emulated, but not duplicated. The 3rd Edition has been thoroughly updated to keep you current with new drugs, changes in FDA labeling, and more in-depth information on interactions. Designed for ease …
Available Online
View e-Book
Author
Weiner, Carl P.
Other Authors
Mason, Clifford
Responsibility
Carl P. Weiner, Clifford Mason
Edition
3rd ed.
Alternate Title
Drugs for pregnant & lactating women
Place of Publication
Philadelphia, PA
Publisher
Elsevier
Date of Publication
c2019
Physical Description
1 online resource, 1170 p.
ISBN
9780323428743
Subjects (MeSH)
Breast Feeding - adverse effects
Contraindications - handbooks
Drug-Related Side Effects and Adverse Reactions
Fetus - drug effects
Infant
Pharmaceutical Preparations - Handbooks
Pregnancy Complications - chemically induced
Pregnancy - drug effects
Subjects (LCSH)
Drug interactions--Handbooks, manuals, etc.
Fetus--Effect of drugs on
Specialty
Pharmacology
Perinatology
Abstract
Comprehensive and easy to use, Drugs for Pregnant and Lactating Women, 3rd Edition, remains your #1 resource for reliable information on virtually all of today’s drugs and herbal supplements and how they interact with pregnancy and lactation. This logically organized reference has been frequently emulated, but not duplicated. The 3rd Edition has been thoroughly updated to keep you current with new drugs, changes in FDA labeling, and more in-depth information on interactions. Designed for ease of use in the clinical setting, it provides the key drug information needed by physicians, nurses, physician assistants, and others involved in the care of pregnant and lactating women.
Access
Registration required for PDF access.
Format
e-Book
Location
Online
Less detail

Drugs for pregnant and lactating women

https://libcat.nshealth.ca/en/permalink/provcat50627
Weiner, Carl P. (3rd ed.) --Philadelphia, PA: Elsevier , 2019.
Available Online
View e-Book
Location
Online
Available Online
View e-Book
Author
Weiner, Carl P.
Other Authors
Mason, Clifford
Edition
3rd ed.
Place of Publication
Philadelphia, PA
Publisher
Elsevier
Date of Publication
2019
ISBN
9780323428743
Subjects (MeSH)
Pregnancy - drug effects
Breast Feeding - adverse effects
Drug-Related Side Effects and Adverse Reactions
Fetus - drug effects
Infant
Pharmaceutical Preparations
Pregnancy Complications - chemically induced
Notes
Access to this online resource is restricted to IWK Health Centre employees working from inside the hospital network.
Format
e-Book
Publication Type
Handbook
Location
Online
Less detail

Drugs in pregnancy and lactation : a reference guide to fetal and neonatal risk

https://libcat.nshealth.ca/en/permalink/provcat38411
Gerald G. Briggs, Roger K. Freeman. (10th ed.) --Philadelphia, PA: Lippincott Williams & Wilkins , c2015.
Call Number
WQ 39 B854d 2015
Location
Cape Breton Regional
Call Number
WQ 39 B854d 2015
Author
Briggs, Gerald G.
Other Authors
Freeman, Roger K.
Responsibility
Gerald G. Briggs, Roger K. Freeman
Edition
10th ed.
Place of Publication
Philadelphia, PA
Publisher
Lippincott Williams & Wilkins
Date of Publication
c2015
Physical Description
1600 p.
ISBN
9781451190823
1451190824
Subjects (MeSH)
Infant, Newborn, Diseases - chemically induced - Handbooks
Drug-Related Side Effects and Adverse Reactions - Handbooks
Lactation - drug effects - Handbooks
Maternal-Fetal Exchange - drug effects - Handbooks
Milk, Human - drug effects - Handbooks
Pregnancy - drug effects - Handbooks
Subjects (LCSH)
Obstetrical pharmacology
Fetus--Effect of drugs on
Newborn infants--Effect of drugs on
Breast milk--Contamination
Population
Pregnancy
Infant, Newborn
Format
Book
Location
Cape Breton Regional
Less detail

Drug Therapy and Interactions in Pediatric Oncology : A Pocket Guide

https://libcat.nshealth.ca/en/permalink/provcat41334
Carolina Witchmichen Penteado Schmidt, Fabiana Gatti de Menezes. --Cham: Springer , 2017.
Available Online
View e-Book
Location
Online
There are few publications about drug interactions in chemotherapy and even less about pediatric oncology treatment. For this reason, the present book is intended to offer guidelines about drug interactions for physicians, pharmacists and the other healthcare professionals involved in the chemotherapy of pediatric patients. In this book the reader will have access to a primary introduction for the major diseases in pediatric oncology, followed by the major therapeutic protocols. Following that,…
Available Online
View e-Book
Author
Penteado Schmidt, Carolina Witchmichen
Other Authors
de Menezes, Fabiana Gatti
Responsibility
Carolina Witchmichen Penteado Schmidt, Fabiana Gatti de Menezes
Place of Publication
Cham
Publisher
Springer
Date of Publication
2017
Physical Description
1 online resource (xxi, 212 pages) : 15 illus. in color
ISBN
9783319388724
9783319388717 (print ed.)
Subjects (MeSH)
Antineoplastic Agents
Drug Interactions
Drug-Related Side Effects and Adverse Reactions - prevention & control
Neoplasms - drug therapy
Abstract
There are few publications about drug interactions in chemotherapy and even less about pediatric oncology treatment. For this reason, the present book is intended to offer guidelines about drug interactions for physicians, pharmacists and the other healthcare professionals involved in the chemotherapy of pediatric patients. In this book the reader will have access to a primary introduction for the major diseases in pediatric oncology, followed by the major therapeutic protocols. Following that, the most important drug interactions in pediatric oncology treatment are presented and discussed in detail. Finally, important topics such as Drug-Food Interactions are addressed. Drug Therapy and Interactions in Pediatric Oncology focuses in great detail on the drug interactions in Pediatric Oncohematology and will be an indispensable resource in daily practice for a wide range of health providers.
Contents
1. Introduction -- 2. The main diseases in pediatric hemato-oncology -- 3. The main protocols in pediatric oncohematology -- 4. Background of drug interactions -- 5. Drug-food interactions -- Appendix -- Glossary.
Format
e-Book
Location
Online
Less detail

Fluoride Toxicity in Animals

https://libcat.nshealth.ca/en/permalink/provcat39285
Rakesh Ranjan, Amita Ranjan. --Cham: Springer , c2015.
Available Online
View e-Book
Location
Online
This book describes in detail various aspects of fluoride toxicity in animals. Animals, like human beings, suffer from the toxic effects of excess fluoride intake. They show pathological changes in their teeth and bone, together with a marked reduction in appetite, productive and reproductive potentials, which can result in severe economic losses in the dairy industry. Laboratory and wild animals also suffer from this ailment. Animal suffering and economic losses alike can be minimized through …
Available Online
View e-Book
Author
Ranjan, Rakesh
Other Authors
Ranjan, Amita
Responsibility
Rakesh Ranjan, Amita Ranjan
Place of Publication
Cham
Publisher
Springer
Date of Publication
c2015
Physical Description
1 online resource (xi, 105 p. : 6 illus. in color)
Series Title
SpringerBriefs in animal sciences
ISBN
9783319175126
9783319175119 (print ed.)
ISSN
2211-7504
Subjects (MeSH)
Animals
Drug-Related Side Effects and Adverse Reactions
Fluorides - toxicity
Fluorine - toxicity
Fluorosis, Dental - veterinary
Toxicology - methods
Veterinary Medicine - methods
Abstract
This book describes in detail various aspects of fluoride toxicity in animals. Animals, like human beings, suffer from the toxic effects of excess fluoride intake. They show pathological changes in their teeth and bone, together with a marked reduction in appetite, productive and reproductive potentials, which can result in severe economic losses in the dairy industry. Laboratory and wild animals also suffer from this ailment. Animal suffering and economic losses alike can be minimized through early diagnosis of the problem and by adopting suitable preventive and therapeutic measures. The book details the susceptibility of different animal species, important sources of toxicity, clinical signs and symptoms, pathophysiology, diagnostic methods, preventive and therapeutic approaches. It offers a valuable resource for scientists working in the fields of toxicology, veterinary science, animal nutrition, and environmental science, as well as for public health workers, animal welfare activists, public health veterinarians, field veterinarians, medical professionals and all others interested in the subject.
Contents
Introduction -- Sources of fluoride toxicity -- Fluoride kinetics and metabolism -- Toxic effects -- Fluoride tolerance -- Fluoride analysis -- Mitigation and prevention of fluorosis -- Appendix.
Format
e-Book
Location
Online
Less detail
Nova Scotia Health. Cancer Care Program. [Halifax, NS]: Nova Scotia Cancer Care Program , 2018.
Pamphlet Number
0005
Available Online
View Pamphlet
Hair loss, known as alopecia (pronounced ‘al-o-peesha’), is a common side effect of cancer treatment. This pamphlet includes information on the amount of hair, why it is being lost, if it will grow back, coping mechanisms for hair loss, and questions to ask your health care team.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health. Cancer Care Program
Place of Publication
[Halifax, NS]
Publisher
Nova Scotia Cancer Care Program
Date of Publication
2018
Format
Pamphlet
Language
English
Physical Description
1 electronic document (3 p.) : digital, PDF file
Subjects (MeSH)
Alopecia
Antineoplastic Agents - adverse effects
Drug-Related Side Effects and Adverse Reactions
Subjects (LCSH)
Antineoplastic agents--Side effects
Baldness
Cancer--Chemotherapy--Complications
Specialty
Self Care
Therapeutics
Abstract
Hair loss, known as alopecia (pronounced ‘al-o-peesha’), is a common side effect of cancer treatment. This pamphlet includes information on the amount of hair, why it is being lost, if it will grow back, coping mechanisms for hair loss, and questions to ask your health care team.
Notes
Patient & family guide
Responsibility
prepared by Nova Scotia Cancer Care Program
Pamphlet Number
0005
Less detail

Hale's medications and mothers' milk : a manual of lactational pharmacology

https://libcat.nshealth.ca/en/permalink/provcat46326
Thomas W. Hale. (19th ed.) --New York, NY: Springer Publishing Company , c2021.
Available Online
View e-Book
Location
Online
Written by a world-renowned expert in perinatal pharmacology, this essential reference contains current, complete, and evidence-based information on the transmission of maternal drugs into human milk. Because so many women ingest medications while breastfeeding, one of the most common questions encountered in pediatrics is: Which drugs are safe and which are hazardous for the infant? This 2021 edition has been extensively revised, and now includes 50 completely new and 356 updated medications,…
Available Online
View e-Book
Author
Hale, Thomas W.
Responsibility
Thomas W. Hale
Edition
19th ed.
Alternate Title
Hale's medications and mothers' milk 2021
Medications and mothers' milk
Medications & mother's milk
Place of Publication
New York, NY
Publisher
Springer Publishing Company
Date of Publication
c2021
Physical Description
1 online resource
ISBN
9780826189264
Subjects (MeSH)
Breast Feeding - adverse effects
Drug-Related Side Effects and Adverse Reactions
Infant, Newborn, Diseases - chemically induced
Milk, Human - metabolism
Specialty
Pediatrics
Pharmacology
Abstract
Written by a world-renowned expert in perinatal pharmacology, this essential reference contains current, complete, and evidence-based information on the transmission of maternal drugs into human milk. Because so many women ingest medications while breastfeeding, one of the most common questions encountered in pediatrics is: Which drugs are safe and which are hazardous for the infant? This 2021 edition has been extensively revised, and now includes 50 completely new and 356 updated medications, and state-of-the-art coverage of multiple diseases, vaccines, and syndromes. It addresses the use of radiopharmaceuticals, chemotherapeutic agents, and vaccines in breastfeeding mothers, and covers adult concerns, methods of reducing risk to infants, and infant monitoring.
Format
e-Book
Publication Type
Handbook
Location
Online
Less detail

Handbook of cancer treatment-related toxicities

https://libcat.nshealth.ca/en/permalink/provcat46233
Vamsi Velcheti, Salman R. Punekar. --Philadelphia, PA: Elsevier , c2022.
Available Online
View e-Book
Access
Registration required for PDF access.
Location
Online
Early recognition and management of adverse effects of cancer treatments are essential for optimal care of patients with cancer, and drastically different approaches are required for different physiologic reactions. Handbook of Cancer Treatment-Related Symptoms and Toxicities is a focused, one-stop resource that enables clinicians to quickly find up-to-date, reliable information needed at the point of care. The high-yield approach prioritizes the most common toxicities associated with cancer t…
Available Online
View e-Book
Author
Velcheti, Vamsi
Responsibility
Vamsi Velcheti, Salman R. Punekar
Alternate Title
Cancer treatment-related toxicities
Place of Publication
Philadelphia, PA
Publisher
Elsevier
Date of Publication
c2022
Physical Description
1 online resource, 466 p.
ISBN
9780323672412
Subjects (MeSH)
Neoplasms
Drug-Related Side Effects and Adverse Reactions
Specialty
Medical Oncology
Pharmacology
Toxicology
Abstract
Early recognition and management of adverse effects of cancer treatments are essential for optimal care of patients with cancer, and drastically different approaches are required for different physiologic reactions. Handbook of Cancer Treatment-Related Symptoms and Toxicities is a focused, one-stop resource that enables clinicians to quickly find up-to-date, reliable information needed at the point of care. The high-yield approach prioritizes the most common toxicities associated with cancer treatment, and concise, templated chapters offer fast access to information needed in day-to-day practice.
Access
Registration required for PDF access.
Format
e-Book
Location
Online
Less detail

Handbook of cancer treatment-related toxicities

https://libcat.nshealth.ca/en/permalink/provcat50776
Velcheti, Vamsi. (1st ed.) --Philadelphia, PA: Elsevier , 2022.
Available Online
View e-Book
Location
Online
Available Online
View e-Book
Author
Velcheti, Vamsi
Other Authors
Punekar, Salman R.
Edition
1st ed.
Place of Publication
Philadelphia, PA
Publisher
Elsevier
Date of Publication
2022
ISBN
9780323672412
Subjects (MeSH)
Neoplasms
Drug-Related Side Effects and Adverse Reactions
Notes
Access to this online resource is restricted to IWK Health Centre employees working from inside the hospital network.
Format
e-Book
Location
Online
Less detail

Low Platelets : Thrombocytopenia

https://libcat.nshealth.ca/en/permalink/chpams37360
Nova Scotia Health. Cancer Care Program. [Halifax, NS]: Nova Scotia Cancer Care Program , 2018.
Pamphlet Number
0032
Available Online
View Pamphlet
Platelets (PLT), thrombocytes, are blood cells that helps it to clot (stop bleeding). Not having enough platelets in your blood is called thrombocytopenia (throm·bo·cy·to·pe·nia). This pamphlets describes what causes low platelets, symptoms, and ways to prevent and manage it.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health. Cancer Care Program
Place of Publication
[Halifax, NS]
Publisher
Nova Scotia Cancer Care Program
Date of Publication
2018
Format
Pamphlet
Language
English
Physical Description
1 electronic document (5 p.) : digital, PDF file
Subjects (MeSH)
Antineoplastic Agents - adverse effects
Blood Coagulation Disorders
Drug-Related Side Effects and Adverse Reactions
Hematologic Diseases
Self Care
Thrombocytopenia
Subjects (LCSH)
Antineoplastic agents--Side effects
Blood cells--Diseases
Blood coagulation disorders
Cancer--Chemotherapy--Complications
Self-care, Health
Thrombocytopenia
Specialty
Hematology
Abstract
Platelets (PLT), thrombocytes, are blood cells that helps it to clot (stop bleeding). Not having enough platelets in your blood is called thrombocytopenia (throm·bo·cy·to·pe·nia). This pamphlets describes what causes low platelets, symptoms, and ways to prevent and manage it.
Notes
Patient & family guide
Responsibility
prepared by Nova Scotia Cancer Care Program
Pamphlet Number
0032
Less detail

Low Red Blood Cells : Anemia

https://libcat.nshealth.ca/en/permalink/chpams37336
Nova Scotia Health. Cancer Care Program. [Halifax, NS]: Nova Scotia Cancer Care Program , 2018.
Pamphlet Number
0002
Available Online
View Pamphlet
Low red blood cell count, called Anemia, can be caused by cancer or cancer treatment. This pamphlet lists the symptoms, treatments, coping mechanisms, and basic questions to ask your health care team.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health. Cancer Care Program
Place of Publication
[Halifax, NS]
Publisher
Nova Scotia Cancer Care Program
Date of Publication
2018
Format
Pamphlet
Language
English
Physical Description
1 electronic document (4 p.) : digital, PDF file
Subjects (MeSH)
Anemia
Antineoplastic Agents - adverse effects
Drug-Related Side Effects and Adverse Reactions
Hematologic Diseases
Radiotherapy - adverse effects
Self Care
Subjects (LCSH)
Anemia
Antineoplastic agents--Side effects
Blood cells--Diseases
Cancer--Chemotherapy--Complications
Radiotherapy--Complications
Self-care, Health
Specialty
Hematology
Abstract
Low red blood cell count, called Anemia, can be caused by cancer or cancer treatment. This pamphlet lists the symptoms, treatments, coping mechanisms, and basic questions to ask your health care team.
Responsibility
prepared by Nova Scotia Cancer Care Program
Pamphlet Number
0002
Less detail

Management of Chemotherapy-Induced Nausea and Vomiting : New Agents and New Uses of Current Agents

https://libcat.nshealth.ca/en/permalink/provcat40025
Rudolph M. Navari, editor. (1st ed.) --Cham: Springer International Publishing : Imprint: Adis , c2016.
Available Online
View e-Book
Location
Online
This book provides a comprehensive review of new agents, a detailed description of new uses of current agents, and an integration of the available agents in clinical practice. A description of a detailed clinical approach provides clinical practitioners with the most up-to-date recommendations for the prevention and treatment of chemotherapy-induced nausea and vomiting (CINV) in various clinical settings. CINV is one of the most feared treatment related toxicities. Patient surveys for the past …
Available Online
View e-Book
Other Authors
Navari, Rudolph M
Responsibility
Rudolph M. Navari, editor
Edition
1st ed.
Place of Publication
Cham
Publisher
Springer International Publishing : Imprint: Adis
Date of Publication
c2016
Physical Description
1 online resource (viii, 181 p. : 17 illus., 9 illus. in color)
ISBN
9783319270166
9783319270142 (print ed.)
Subjects (MeSH)
Antiemetics - therapeutic use
Drug-Related Side Effects and Adverse Reactions
Nausea - chemically induced
Nausea - drug therapy
Neoplasms - drug therapy
Vomiting - chemically induced
Vomiting - drug therapy
Abstract
This book provides a comprehensive review of new agents, a detailed description of new uses of current agents, and an integration of the available agents in clinical practice. A description of a detailed clinical approach provides clinical practitioners with the most up-to-date recommendations for the prevention and treatment of chemotherapy-induced nausea and vomiting (CINV) in various clinical settings. CINV is one of the most feared treatment related toxicities. Patient surveys for the past thirty years consistently demonstrate patients' perception of deterioration in quality of life due to chemotherapy treatments. The introduction of the antiemetics, serotonin 5-HT3 receptor antagonists and the neurokinin-1 receptor antagonists, have improved the control of chemotherapy-induced emesis, but the treatment of chemotherapy-induced nausea remains a significant clinical problem. Patients continue to have quality of life issues which prevent normal functioning during active treatment. New agents such as the second generation 5-HT3 receptor antagonist palonosetron and the new neuroknin-1 receptor antagonists rolapitant and netupitant are being introduced into clinical practice, and it is anticipated that these new agents will improve the control of CINV. Agents such as olanzapine (a FDA approved anti-psychotic), gabapentin (a FDA approved neuroleptic), and ginger (a food additive), which have been used primarily for other indications, are now being tested as potential, effective antiemetics. This work represents the first available comprehensive summary that details all new antiemetic agents and, particularly, their clinical role in treating patients; an important reference for practitioners seeking to improve the quality of life of patients undergoing chemotherapy.
Contents
1. Introduction -- 2. The Physiology and Pharmacology of Nausea and Vomiting Induced by Anti-Cancer Chemotherapy in Humans -- 3. First Generation 5HT-3 Receptor Antagonists -- 4. Second Generation Serotonin (5-HT3) Receptor Antagonist Palonosetron -- 5. The Role of Neurokinin-1 Receptor Antagonists in CINV -- 6. Olanzapine for the prevention of Chemotherapy-Induced Nausea and Vomiting -- 7. Gabapentin for the Prevention of CINV -- 8. Prevention of CINV in Patients Receiving High-Dose Multiple-Day Chemotherapy -- 9. Clinical Management of CINV -- 10. Treatment of Chemotherapy-Induced Nausea -- 11. Conclusions -- 12. Future Directions.
Format
e-Book
Location
Online
Less detail

Medical Management of Psychotropic Side Effects

https://libcat.nshealth.ca/en/permalink/provcat41660
Aniyizhai Annamalai. --Cham: Springer , 2017.
Available Online
View e-Book
Location
Online
This book is a practical guide for psychiatrists to use when treating patients for medical issues. Over the past 10-20 years, the number of medications prescribed for psychiatric illnesses has steadily increased, and psychiatric practitioners are frequently called upon to manage medical issues and side effects that result from psychotropic treatment. Covering a wide range of conditions from thyroid disorders to cardiac disease, this book is a helpful resource for understanding common adverse me…
Available Online
View e-Book
Author
Annamalai, Aniyizhai
Responsibility
Aniyizhai Annamalai
Place of Publication
Cham
Publisher
Springer
Date of Publication
2017
Physical Description
1 online resource (xx, 304 pages) : 48 illus., 45 illus. in color
ISBN
9783319510262
9783319510248 (print ed.)
Subjects (MeSH)
Drug-Related Side Effects and Adverse Reactions
Psychotropic Drugs - adverse effects
Psychotropic Drugs - therapeutic use
Abstract
This book is a practical guide for psychiatrists to use when treating patients for medical issues. Over the past 10-20 years, the number of medications prescribed for psychiatric illnesses has steadily increased, and psychiatric practitioners are frequently called upon to manage medical issues and side effects that result from psychotropic treatment. Covering a wide range of conditions from thyroid disorders to cardiac disease, this book is a helpful resource for understanding common adverse medical effects that occur when psychotropic drugs are administered. Presented in a practical format, each chapter discusses management of a particular medical problem or side effect and then provides a summary and flowchart of the major points highlighted in that chapter. Each chapter contains an overview of key medications causing a particular side effect. The book also includes special topics such as psychotropic prescribing in medical illness and tips on electrocardiographic interpretation. This easy-to-reference book aims to bridge the gap between medicine and psychiatry by elaborating on medical conditions seen in routine outpatient psychiatric practice. It serves as an invaluable tool for mental health providers, nurses, health educators, and pharmacologists alike.
Contents
Part I: Psychotropic Prescribing in Medically Ill Patients -- 1. Psychotropic prescribing in medically ill patients -- Part II: Metabolic syndrome -- 2. Obesity -- 3. Diabetes mellitus and acute hyperglycemia -- 4. Hypertension and acute hypertensive crisis -- 5. Hyperlipidemia -- Part III: Cardiovascular system -- 6. Orthostatic hypotension -- 7. Tachycardia and myocarditis -- 8. QTc prolongation -- 9. Non-QT conduction abnormalities -- 10. Peripheral edema -- 11. Appendix: Miscellaneous electrocardiographic abnormalities -- Part IV: Endocrine system -- 12. Hyperprolactinemia -- 13. Thyroid disorders -- 14. Hypercalcemia -- Part V: Kidney and electrolytes -- 15. Diabetes insipidus -- 16. Hyponatremia -- 17. Chronic kidney disease -- Part VI: Genitourinary system -- 18. Sexual dysfunction -- 19. Urinary incontinence and retention -- Part VII: Oral and gastrointestinal system -- 20. Hepatitis -- 21. Pancreatitis -- 22. Constipation -- 23. Sialorrhea -- 24. Bruxism -- Part VIII: Hematologic system -- 25. Introduction to blood cell disorders -- 26. Leukopenia -- 27. Platelet function disorders -- 28. Thrombocytopenia -- 29. Anemia -- 30. Pancytopenia -- 31. Leukocytosis -- 32. Eosinophilia -- Part IX: Dermatology -- 33. Drug-induced cutaneous reactions -- Part X: Neurologic system -- Part Xa: Movement disorders -- 34. Introduction to movement disorders -- 35. Tremor -- 36. Extrapyramidal symptoms I (Parkinsonism) -- 37. Extrapyramidal symptoms II (Dystonia, akathisia, tardive dyskinesia) -- 38. Tics -- Part Xb: Systemic syndromes -- 39. Myoclonus and serotonin syndrome -- 40. Creatine kinase elevation and neuroleptic malignant syndrome -- Part Xc: Other neurologic conditions -- 41. Seizures -- 42. Altered mental status -- Part XI: Others -- 43. Xerostomia -- 44. Sedation -- 45. Priapism -- 46. Polycystic ovarian syndrome -- 47. Osteoporosis -- 48. Drug-induced lupus -- 49. Cataracts -- 50. Nephrolithiasis.
Format
e-Book
Location
Online
Less detail

34 records – page 1 of 2.